1-10
Cancer variation associated with the position of the mutation in the BRCA2 gene
Jan Lubinski, Catherine M. Phelan, Parviz Ghadirian, Henry T. Lynch and Judy Garber, et al.
11-14
The 1100delAT BRCA1 and the 8765delAG BRCA2 Mutations: Occurrence in High-Risk Non-Ashkenazi Jews and Haplotype Comparison of Jewish and Non-Jewish Carriers
Inbar Gal, Ruth Gershoni Baruch, Daniel Haber, Efrat Dagan and Shlomit Eisenberg-Barzilai, et al.
15-20
BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect
Danièle Muller, Catherine Bonaiti-Pelié, Joseph Abecassis, Dominique Stoppa-Lyonnet and Jean-Pierre Fricker
21-28
BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample
Jon G. Reichelt, Ketil Heimdal, Pål Møller and Alv A. Dahl
29-34
An audit of screening for familial breast cancer before 50 years in the South Thames Region – have we got it right?
Victoria Murday, R. Pears, J. Ball, R. Eeles and S. Hodgson
35-40
Intron 4 Mutation in APC Gene Results in Splice Defect and Attenuated FAP Phenotype
Deborah W. Neklason, Cindy H. Solomon, Amy L. Dalton, Scott K. Kuwada and Randall W. Burt
41-47
Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry
Fáblio Oliveira Ferreira, Claudia Cristina Napoli Ferreira, Benedito Mauro Rossi, Wilson Toshihiko Nakagawa and Samuel Aguilar, et al.
49-53
Patients' and professionals' opinions of services for people at an increased risk of colorectal cancer: an exploratory qualitative study
Tamar Stermer, Shirley Hodgson, Fred Kavalier, Sally Watts and Roger Jones
55-59
Delivering Information about Cancer Genetics via Letter to Patients at Low and Moderate Risk of Familial Cancer: A Pilot Study in Wales
C. Phelps, K. Platt, L. France, J. Gray and R. Iredale
61-67
Health economics and genetic service development: a familial cancer genetic example
David Cohen, Garry Barton, Jonathon Gray and Kate Brain
69-74
Familial Pancreatic Cancer
Harald Rieder and Detlef K. Bartsch
75-77
Familial Cancer 2003 – Research and Practice, Couran Cove, Queensland, Australia, 3–6 September 2003
Geoffrey J. Lindeman
79-81
Instructions for authors